Abstract:Introduction Hyperhidrosis, the excessive and uncontrollable sweating, is a well-documented side effect of various medications. Among these, bupropion, a commonly prescribed antidepressant and smoking cessation aid, has been associated with the development of severe hyperhidrosis in a subset of patients. This clinical report aims to shed light on a compelling case of severe hyperhidrosis induced by bupropion use and the subsequent treatment strategies employed The patient under discussion is a 42-year-old female with a history of recurrent major depressive disorder and a previous favorable response to selective serotonin reuptake inhibitors (SSRIs). Due to side effect concerns and a desire to quit smoking, she was transitioned to bupropion, a norepinephrine-dopamine reuptake inhibitor (NDRI), at a standard therapeutic dose of 150 mg daily. Approximately four weeks after initiating bupropion therapy, the patient began experiencing debilitating symptoms of excessive sweating, particularly affecting her palms, soles, and axillae. The profuse sweating episodes occurred throughout the day and night, significantly impairing her quality of life, social interactions, and occupational functioning. No previous history of hyperhidrosis was reported, and physical examinations revealed no underlying medical conditions or dermatological issues. Objectives To aknowledge the importance of recognizing and addressing medication-induced side effects within the realm of psychiatry and an early implementation of patient-centered treatment. Methods Clinical case report and a brief literature review. Results The treatment of hyperhidrosis secondary to bupropion use presents a challenging clinical scenario that requires a delicate balance between managing the distressing side effect and ensuring the continued efficacy of psychiatric therapy. Given the rarity of severe hyperhidrosis as a side effect of bupropion, there is a limited body of evidence guiding treatment strategies. Gradual withdrawal in the dose of bupropion was initiated, with careful monitoring of depressive symptoms to prevent relapse, switching to Duloxetine 90mg daily, with adecuate efectiveness.In this particular case, the combination of medication adjustment and psychological support led to a significant reduction in hyperhidrosis symptoms. The patient reported improved social interactions, enhanced self-esteem, and restored occupational functioning. Importantly, her depressive symptoms remained well-managed, underscoring the success of the treatment strategy. Conclusions This clinical report highlights the importance of a patient-centered approach when addressing rare medication-induced side effects within the field of psychiatry. Bupropion withdrawal and regular follow-up showed effective in the treatment of the simptoms. Future research may provide additional insights and treatment options for cases like this, further enhancing patient care and outcomes. Disclosure of Interest None Declared

Bupropion-Induced Dystonia: A Case Report

Bupropion-induced acute dystonia in a patient with bulimia nervosa: A case report

Bupropion-Induced Myoclonus: Case Report and Review of the Literature

BUPROPION INDUCED DELAYED ONSET URTICARIA: A CASE REPORT

Severe Hyperhidrosis Secondary to Bupropion Use and Treatment. A case report.

Peptic Ulcer Disease Following Use of Bupropion: A Case Report

Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation

Clinical Presentations of Bupropion Prescription Drug Misuse

Bupropion-disguised chest pain presenting in a middle-aged male: a case report and review of literature

Delayed allergic reaction from bupropion in a 27-year-old male with MDD: A case report and literature review

Dextromethorphan Induced Dystonia: A Rare Case Report

Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database

Aripiprazole Augmentation in Managing Comorbid Obsessive-Compulsive Disorder and Bipolar Disorder: a Case with Suicidal Attempts.

Case Report: Bupropion Reduces the [123I]FP-CIT Binding to Striatal Dopamine Transporter

Erythrodermic Psoriasis Exacerbated by Bupropion

Effects of Bupropion Sustained-Release on Sexual Functioning and Nocturnal Erections in Healthy Men

Bupropion: Does Its Efficacy Outweigh Potential Morbidity and Lethality?

Cardiovascular Collapse Requiring Veno-Arterial Extracorporeal Membrane Oxygenation and Lidocaine: A Case of Massive Bupropion Overdose

Exposure to Bupropion-SR vs. Placebo is associated with reductions in smoking among persons receiving methadone with no stated interest in smoking cessation

Symptoms of exhibitionism that regress with bupropion: A case report

Does Bupropion Increase Anxiety?: A Naturalistic Study Over 12 Weeks